R&D Success in Pharmaceutical Markets: A Duration Model Approach

Eliana Barrenho and Marisa Miraldo

A chapter in Health Econometrics, 2018, vol. 294, pp 201-233 from Emerald Group Publishing Limited

Abstract: This chapter aims at providing an understanding of the research and devlopment (R&D) process in the pharmaceutical industry, by exploring the methodological challenges and approaches in the assessment of the determinants of innovation in the pharmaceutical industry. It (i) discusses possible methodological approaches to model occurrence of events; (ii) describes in detail competing risks duration models as the best methodological option in light of the nature of pharmaceutical R&D processes and data; (iii) concludes with an estimation strategy and overview of potential covariates that have been found to correlate with the likelihood of failure of R&D pharmaceutical projects.

Keywords: Technical paper; pharmaceutical R&D; failure; duration models (search for similar items in EconPapers)
Date: 2018
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.emerald.com/insight/content/doi/10.110 ... d&utm_campaign=repec (text/html)
https://www.emerald.com/insight/content/doi/10.110 ... 3-855520180000294010
https://www.emerald.com/insight/content/doi/10.110 ... d&utm_campaign=repec (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eme:ceazzz:s0573-855520180000294010

DOI: 10.1108/S0573-855520180000294010

Access Statistics for this chapter

More chapters in Contributions to Economic Analysis from Emerald Group Publishing Limited
Bibliographic data for series maintained by Emerald Support ().